Zimmer Biomet PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
113.16
-0.10(-0.09%)
After Hours
109.47
-3.69(-3.26%)
- Real-time Data
- Volume:534,218
- Day's Range:113.00 - 114.37
- 52 wk Range:100.39 - 149.17
ZBH Overview
- Prev. Close
- 113.26
- Day's Range
- 113-114.37
- Revenue
- 7.92B
- Open
- 113.83
- 52 wk Range
- 100.39-149.17
- EPS
- 1.1
- Volume
- 534,218
- Market Cap
- 23.72B
- Dividend (Yield)
- 0.96(0.85%)
- Average Vol. (3m)
- 1,215,868
- P/E Ratio
- 82.09
- Beta
- 1.15
- 1-Year Change
- -21.71%
- Shares Outstanding
- 209,577,347
- Next Earnings Date
- Nov 03, 2022
What is your sentiment on Zimmer Biomet?
or
Market is currently closed. Voting is open during market hours.
Zimmer Biomet Holdings Inc News
- Stock Market Today: Dow Falls on Caterpillar Slump, Rising Geopolitical Tensions
- ByInvesting.com-
- 32
By Yasin EbrahimInvesting.com -- The Dow fell Tuesday, weighed down by rising geopolitical tensions and a slip in Caterpillar on weaker-than-expected revenue.The Dow Jones...
- Zimmer Biomet PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Zimmer Biomet Holdings Inc Analysis
- Zimmer Biomet (ZBH) Q4 Earnings Miss Estimates, Margins Down
Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH posted fourth-quarter 2021 adjusted earnings per share (EPS) of $1.95, a penny short of the Zacks Consensus Estimate. The adjusted...
- Strength Seen in Zimmer (ZBH): Can Its 4.7% Jump Turn into More Strength?
Zimmer Biomet (ZBH) shares rallied 4.7% in the last trading session to close at $147.68. This move can be attributable to notable volume with a higher number of shares being traded...
- Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic
Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH continues to gain market share in the Asia Pacific, Europe, the Middle East and Africa (EMEA) regions. However, slower recovery amid the...
Zimmer Biomet Holdings Inc Company Profile
Zimmer Biomet Holdings Inc Company Profile
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The Company is engaged in the design, manufacture and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. It operates through four segments: Americas Orthopedics, Europe, Middle East and Africa (EMEA), Asia Pacific, and Americas Spine and Global Dental. Its knee brands include Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. Its S.E.T. brands include JuggerKnot Soft Anchor System, Gel-One1 Cross-linked Hyaluronate, Comprehensive Shoulder and others.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Neutral | Buy | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Sell | Strong Buy | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 90.82 | 92.75 | 90.34 | -1.74 | -1.88% | 14.55M | NYSE | |||
| 100.07 | 101.80 | 97.99 | -2.24 | -2.19% | 90.72M | NASDAQ | |||
| 30.58 | 31.52 | 30.15 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 270.17 | 273.15 | 269.73 | +1.11 | +0.41% | 477.44K | NYSE | |||
| 49.57 | 49.81 | 48.94 | +0.30 | +0.61% | 14.99M | NYSE | |||
| 60.04 | 60.60 | 58.34 | +1.03 | +1.75% | 18.12M | NYSE | |||
| 129.03 | 130.70 | 128.01 | -0.19 | -0.15% | 807.47K | NASDAQ | |||
| 18.38 | 18.53 | 18.27 | +0.14 | +0.77% | 2.03M | NYSE | |||
| 247.29 | 247.74 | 244.31 | +1.04 | +0.42% | 2.78M | NASDAQ | |||
| 15.14 | 15.23 | 14.88 | +0.91 | +6.39% | 3.93M | OTC Markets | |||
| 47.09 | 47.60 | 46.96 | -0.16 | -0.34% | 2.97M | NYSE | |||
| 11.41 | 13.34 | 10.75 | +3.25 | +39.83% | 120.50M | NASDAQ | |||
| 144.58 | 146.48 | 139.80 | +5.59 | +4.02% | 1.59M | NYSE | |||
| 423.86 | 429.37 | 421.67 | -2.55 | -0.60% | 814.73K | NYSE | |||
| 7.86 | 8.23 | 7.85 | 0.00 | 0.00% | 1.40M | NASDAQ |
- Sep 17, 2021, 06:05Was already priced in. Profit taking. Buy at $140
- Aug 05, 2021, 06:35"Zimmer Biomet reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations." So, why the sell off?
- Mar 16, 2020, 23:10Great opportunity at 80$